Warfarin dose requirement during induction correlates with CYP2C9 genetic polymorphism.

被引：0
|
作者：
Muszkat, M [1 ]
Elami, A [1 ]
Krasilnikov, I [1 ]
Caraco, Y [1 ]
机构：
[1] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2002年 / 71卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P37 / P37
页数：1
相关论文
共 50 条
  • [1] Effect of CYP2C9 and VKORC1 genetic polymorphism on Warfarin dose requirement
    Ashavaid, T. F.
    Ponde, C. K.
    Raghavan, R.
    Kapadia, F. N.
    Shah, S. A.
    Natarajan, S.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 507 - 508
  • [2] CYP2C9 polymorphism and warfarin dose requirements
    Daly, AK
    Day, CP
    Aithal, GP
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (04) : 408 - 409
  • [3] Genetic polymorphism of CYP2C9 and warfarin dose predicting in anticoagulation therapy
    Stefanovic, M
    Topic, E
    Samardzija, M
    CLINICAL CHEMISTRY, 2005, 51 : A151 - A151
  • [4] Warfarin dose requirement and CYP2C9 polymorphisms -: Reply
    Aithal, GP
    Day, CP
    Kesteven, PJL
    Daly, AK
    LANCET, 1999, 353 (9168): : 1972 - 1973
  • [5] Association between CYP2C9 polymorphism and warfarin dose
    Samardzija, M.
    Topic, E.
    Stefanovic, M.
    Zibar, L.
    Samardzija, G.
    Balen, S.
    Vcev, A.
    Domanovic, D.
    Barbic, J.
    Petrak, D.
    Sisljagic, V.
    BLOOD REVIEWS, 2007, 21 : S69 - S69
  • [6] Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy
    Furuya, H
    FernandezSalguero, P
    Gregory, W
    Taber, H
    Steward, A
    Gonzalez, FJ
    Idle, JR
    PHARMACOGENETICS, 1995, 5 (06): : 389 - 392
  • [7] The impact of patient age and genetic polymorphism of CYP2C9 on warfarin dose requirements
    Kamali, F
    Khan, TI
    King, BP
    Frearson, R
    Kesteven, P
    Wood, P
    Daly, AK
    Wynne, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (05) : 668 - 668
  • [8] A study on the relationship between warfarin dose and CYP2C9 polymorphism
    Yeneka, LA
    Hung, A
    Gaffney, D
    CLINICA CHIMICA ACTA, 2005, 355 : S388 - S388
  • [9] Genetic polymorphism of the CYP2C9 subfamily of 3 different races in warfarin maintenance dose
    Gan, GG
    Phipps, ME
    Ku, CS
    Teh, A
    Sangkar, V
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 80 (03) : 295 - 296
  • [10] Genetic Polymorphism of the CYP2C9 Subfamily of 3 Different Races in Warfarin Maintenance Dose
    Gin Gin Gan
    Alan Teh
    Vijaya Sangkar
    Maude Elvira Phipps
    Chee Seng Ku
    International Journal of Hematology, 2004, 80 : 295 - 296
12345